Guardant Health
The researchers used publicly available data from companies such as Guardant Health, Exact Sciences, and Geneoscopy to determine possible effects of blood-based tests.
Exact Sciences Blood-Based Colon Cancer Screening Data at ESMO Exceeds Expectations
Although the results were better than expected, the company cautioned that it expects lower performance in its prospective trial readout, planned for early next year.
Italian Hospital System to Offer Guardant360 CDx Liquid Biopsy Service for Cancer Therapy Selection
Rome-based Policlinico Gemelli will establish an in-house liquid biopsy testing service within its hospital system utilizing Guardant360 CDx.
360Dx Top 30 Ticks up 2 Percent in August
Of the 30 companies in the index, 17 saw their share price increase, 12 saw their stock price decline, and one remained flat month over month.
Guardant Health Liquid Biopsy CDx Gets Japanese Regulatory Approval for Janssen Lung Cancer Drug
Patients with inoperable or recurrent NSCLC and EGFR exon 20 insertion mutations may be eligible for Janssen Pharmaceutical's amivantamab-vmjw.